CN Patent

CN105294696A — 依鲁替尼新晶型及其制备方法

Assigned to Aopudun (shanghai) Medical Technology Co Ltd · Expires 2016-02-03 · 10y expired

What this patent protects

本发明提供了两种依鲁替尼的晶型及其制备方法和应用。具体地，本发明提供了1-[(3R)-3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基]-1-哌啶基]-2-丙烯-1-酮的晶型及其制备方法和应用。

USPTO Abstract

本发明提供了两种依鲁替尼的晶型及其制备方法和应用。具体地，本发明提供了1-[(3R)-3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基]-1-哌啶基]-2-丙烯-1-酮的晶型及其制备方法和应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN105294696A
Jurisdiction
CN
Classification
—
Expires
2016-02-03
Drug substance claim
No
Drug product claim
No
Assignee
Aopudun (shanghai) Medical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.